Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, published its Sustainability Report 2021. It illustrates that the company is driving innovation towards lower emissions, invests in R&D to create a more sustainable cold chain, and that collaboration is the way towards a more sustainable industry.
Commenting on the report, CEO, Peter Gisel-Ekdahl, said:
“Our solutions minimize pharma product losses and increase circularity as well as resource efficiency, as our leased cold chain solutions are re-used hundreds of times during their lifetime. The pharmaceuticals we transport are crucial for millions of patients worldwide. Sustainability is extremely important to us, and our ambition is to take a leading role in the transformation towards a more sustainable pharmaceutical cold chain.”
Based on Envirotainer’s market leading position, unique ecosystem, strong product and service portfolio, and passion for innovation, the ambition is to lead the transformation to a more sustainable pharmaceutical cold chain.
With 80-90 per cent of CO2 emissions in the pharmaceutical value chain coming from production and raw materials, stopping waste through temperature deviations in transport is vital. Envirotainer has temperature deviations of less than 0.1%, which is industry-leading.
The business also supports a circular economy where its cold chain solutions are re-used hundreds of times during their lifetime. Its latest innovation, the Releye range of containers, can reduce CO2 emissions by 90% compared to passive shipment solutions. Envirotainer is driving the shift from passive to active solutions.
The Sustainability Report, along with additional information available on the website, describes Envirotainer’s economic, environmental and social impact. It addresses the sustainability initiatives and performance in 2021, and includes Envirotainer’s ambitions, priorities, goals, achievements and key sustainability performance indicators.
The full report is available here